Endpoint Health fetches $52m Series A

Endpoint Health Inc, a precision-firstTM therapeutics company, has secured $52 million in Series A funding.

2 June 2022•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Deals & Exits Healthcare Briefs